Hepatic lipase (HL)-mediated lipolysis of the TG-enriched HDL and LDL generates rapidly catabolizing small-dense HDL and atherogenic small-dense LDL, the hallmarks of MS dyslipidemia [11,12]. This evidence concerns the gene LIPC and metabolic syndrome.